1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of PLSCR2 mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PLSCR2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLSCR2 mRNA CTD PMID:15034205 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PLSCR2 promoter] CTD PMID:19654925 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLSCR2 mRNA CTD PMID:16054899 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of PLSCR2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis4-hydroxyphenylsulfone results in increased expression of PLSCR2 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of PLSCR2 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of PLSCR2 mRNA CTD PMID:28973697 antirheumatic drug decreases expression ISO RGD:1353834 6480464 Antirheumatic Agents results in decreased expression of PLSCR2 mRNA CTD PMID:24449571 benzo[a]pyrene multiple interactions EXP 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of PLSCR2 mRNA, AHR protein promotes the reaction [Benzoapyrene results in decreased expression of PLSCR2 mRNA] CTD PMID:15034205 , PMID:27858113 benzo[a]pyrene increases methylation ISO RGD:1353834 6480464 Benzoapyrene results in increased methylation of PLSCR2 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1353834 6480464 Benzoapyrene affects the methylation of PLSCR2 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of PLSCR2 mRNA CTD PMID:15034205 , PMID:19770486 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of PLSCR2 mRNA CTD PMID:27858113 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PLSCR2 mRNA CTD PMID:30245210 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of PLSCR2 mRNA CTD PMID:25554681 chrysene multiple interactions EXP 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of PLSCR2 mRNA CTD PMID:27858113 ciguatoxin CTX1B affects expression EXP 6480464 Ciguatoxins affects the expression of PLSCR2 mRNA CTD PMID:18353800 copper atom multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PLSCR2 mRNA CTD PMID:15467011 copper(0) multiple interactions EXP 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of PLSCR2 mRNA CTD PMID:15467011 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of PLSCR2 mRNA CTD PMID:19770486 dexamethasone multiple interactions EXP 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of PLSCR2 mRNA CTD PMID:16054899 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PLSCR2 mRNA CTD PMID:30529165 lipopolysaccharide affects expression EXP 6480464 Lipopolysaccharides affects the expression of PLSCR2 mRNA CTD PMID:17590392 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-2-ethylhexylphthalate results in increased expression of PLSCR2 mRNA CTD PMID:22401849 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PLSCR2 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of PLSCR2 mRNA CTD PMID:12595580 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of PLSCR2 mRNA CTD PMID:23091169 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of PLSCR2 mRNA CTD PMID:19270015 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of PLSCR2 mRNA CTD PMID:17426115 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PLSCR2 mRNA CTD PMID:18445702 , PMID:23811191 sodium arsenite affects methylation ISO RGD:1353834 6480464 sodium arsenite affects the methylation of PLSCR2 gene CTD PMID:28589171 succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PLSCR2 mRNA CTD PMID:26378955 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of PLSCR2 mRNA CTD PMID:17484886 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PLSCR2 mRNA CTD PMID:27339419 , PMID:31919559 tetraphene multiple interactions EXP 6480464 [Benzoapyrene co-treated with benzaanthracene co-treated with benzobfluoranthene co-treated with chrysene] results in increased expression of PLSCR2 mRNA CTD PMID:27858113 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of PLSCR2 mRNA CTD PMID:23409001 trimellitic anhydride decreases expression EXP 6480464 trimellitic anhydride results in decreased expression of PLSCR2 mRNA CTD PMID:19042947 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of PLSCR2 mRNA CTD PMID:17292431